Nausheen Ahmed, MD
Advertisement
Nausheen Ahmed, MD, is an associate professor of hematologic malignancies and cellular therapeutics at the University of Kansas Medical Center.
Articles by Nausheen Ahmed, MD
Nausheen Ahmed, MD, discusses the guidelines for monitoring patients after receiving CAR T-cell therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
AMH Testing Predicts Chemotherapy Benefit in RxPONDER Breast Cancer
3
How the Immune System Drives Nerve Growth in TNBC
4
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
5